Number of Patients (N = 45)
Predicted Site of Origin Tissue of Origin Test Veridex 10-Gene Assay*
Lung, non-small cell 11 10
Pancreas 6 7
Sarcoma 6 -
Ovary 5 3
Colon 4 4
Kidney 3 -
Liver 3 -
Breast 2 0
Stomach 2 -
Bladder 1 -
Prostate 0 0
Other 0 19
Unsuccessful 0 2
Non-diagnostic 2 0
*The Veridex 10-gene assay allows detection of 6 sites of origin (lung, pancreas, ovary, colon, breast, prostate). Cancers with gene signatures not matching any of the 6 included types were categorized as “other.”
Table 2: Summary of Predictions by the Tissue of Origin Test and the Veridex 10- Gene Assay.